Pharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing – business live
NeutralWorld Affairs

In a surprising move, GSK has appointed a new CEO following the departure of Dame Emma Walmsley, marking a significant shift in leadership for the pharmaceutical giant. This change comes as AstraZeneca also makes headlines with its announcement of a stock market listing in New York. These developments are crucial as they reflect the ongoing evolution within the pharmaceutical industry, potentially impacting investors and the market landscape.
— Curated by the World Pulse Now AI Editorial System